Genome Institute of Singapore:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Genome Institute of Singapore - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9369
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:シンガポール
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genome Institute of Singapore (GIS) is a research institute that provides research programs and services in different areas. The institute concentrates on genomic sciences to improve public health and prosperity in Singapore. It operates technology and comprises early career researchers such as next generation sequencing, genome engineering, genotyping, high-throughput biology, cytogenetics and single cell genomics, among others. GIS also performs research in human genomics, genomics technologies, cancer stem cell biology, cancer genomics, infectious diseases, tissue regeneration, and computational biology areas, among others. The institute offers its services to PhD, MD and M.B.B.S. graduates through its GIS Fellow Programs, to carry their research projects. GIS is headquartered in Singapore.

Genome Institute of Singapore – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genome Institute of Singapore, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Genome Institute of Singapore, Medical Devices Deals, 2012 to YTD 2018 9
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Singapore Research and Health Institutes Enters into Development Agreement with C&C Research Labs 11
Atreca Enters into Agreement with Genome Institute of Singapore 12
InvitroCue Enters into Research Agreement with Genome Institute of Singapore 13
PerkinElmer Forms Joint Venture with Genome Institute of Singapore 14
Genome Institute of Singapore Extends Research Agreement with Pacific Biosciences 15
Genome Institute of Singapore Enters Into Agreement With Oxford Biodynamics For Stem Cell Epigenetic Signatures 16
Genome Institue of Singapore Partners With Fluidigm To Establish Single-Cell Genomics Research Center 17
Appistry Enters Into Co-Development Agreement With Genome Institute of Singapore 18
Genome Institute of Singapore – Key Competitors 19
Genome Institute of Singapore – Key Employees 20
Genome Institute of Singapore – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Joint Venture 21
Recent Developments 22
Strategy And Business Planning 22
Jul 24, 2017: Launch of New Joint Innovation Laboratory to Advance Personalised Medicine for Cancer Treatment 22
Jul 20, 2017: InvitroCue and Genome Institute of Singapore establish joint innovation laboratory for the development of in vitro cancer models 23
Government and Public Interest 24
Apr 12, 2018: Synthetic Macromolecules Proven to Kill Multidrug-resistant Cancer Cells, Prevent the Spread of Cancer, and Avert Drug Resistance Development 24
Mar 13, 2018: Treating liver failure with stem cell-derived liver cells in the future 25
Jan 31, 2018: Discovery of molecular nets inside heart muscles hold promise for new treatment 26
Nov 28, 2017: Genome Institute of Singapore: A Step Forward In Mending Damaged Lungs Using Stem Cells 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Key Facts 2
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genome Institute of Singapore, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genome Institute of Singapore, Deals By Therapy Area, 2012 to YTD 2018 8
Genome Institute of Singapore, Medical Devices Deals, 2012 to YTD 2018 9
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Singapore Research and Health Institutes Enters into Development Agreement with C&C Research Labs 11
Atreca Enters into Agreement with Genome Institute of Singapore 12
InvitroCue Enters into Research Agreement with Genome Institute of Singapore 13
PerkinElmer Forms Joint Venture with Genome Institute of Singapore 14
Genome Institute of Singapore Extends Research Agreement with Pacific Biosciences 15
Genome Institute of Singapore Enters Into Agreement With Oxford Biodynamics For Stem Cell Epigenetic Signatures 16
Genome Institue of Singapore Partners With Fluidigm To Establish Single-Cell Genomics Research Center 17
Appistry Enters Into Co-Development Agreement With Genome Institute of Singapore 18
Genome Institute of Singapore, Key Competitors 19
Genome Institute of Singapore, Key Employees 20
Genome Institute of Singapore, Joint Venture 21

List of Figures
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genome Institute of Singapore, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Genome Institute of Singapore, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Genome Institute of Singapore:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • USANA Health Sciences Inc (USNA):企業の財務・戦略的SWOT分析
    USANA Health Sciences Inc (USNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • SSM Health Care:企業の戦略的SWOT分析
    SSM Health Care - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Edison SpA (EDNR):企業の財務・戦略的SWOT分析
    Edison SpA (EDNR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Symbiotec Pharmalab Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Symbiotec Pharmalab Ltd (Symbiotec) is a medical laboratory that manufactures active pharmaceutical ingredients. The laboratory develops, produces and markets research-based cortico steroids and steroid-hormone APIs. Its cortico-steroids APIs include clobetasol propionate, betamethasone dipr …
  • Serco Group plc (SRP):企業の財務・戦略的SWOT分析
    Serco Group plc (SRP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Infinity Energy Resources Inc (IFNY):石油・ガス:M&Aディール及び事業提携情報
    Summary Infinity Energy Resources Inc (Infinity Energy) is an oil and gas company that offers exploration and development of crude oil resources. The company operates oil and gas concessions located at offshore Nicaragua in the Caribbean Sea. Its concessions are located adjacent to Noble Energy’s of …
  • Ferring International Center SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Ferring International Center SA (Ferring) researches, develops and markets pharmaceutical products. The company offers pharmaceutical products in the fields of reproductive health, gastroenterology, endocrinology, urology and orthopedics. Some of the marketed products include Rekovelle (foll …
  • Arbor Pharmaceuticals LLC-製薬・医療分野:企業M&A・提携分析
    Summary Arbor Pharmaceuticals LLC (Arbor) is a healthcare products provider that develops prescription products for the hospital, cardiovascular and pediatric segments. The company offers licensing, manufacturing, development and commercialization of late-stage prescription products. It also offers …
  • Ralph Lauren Corp:企業の戦略・SWOT・財務分析
    Ralph Lauren Corp - Strategy, SWOT and Corporate Finance Report Summary Ralph Lauren Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Grupo Televisa S.A.B.:企業の戦略・SWOT・財務分析
    Grupo Televisa S.A.B. - Strategy, SWOT and Corporate Finance Report Summary Grupo Televisa S.A.B. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Nemus Bioscience Inc (NMUS):製薬・医療:M&Aディール及び事業提携情報
    Summary Nemus Bioscience Inc (Nemus Bioscience) is a life-science and biopharmaceutical company that offers discovering, developing and commercializing cannabinoid-based therapeutics. The company’s drug pipeline products include NB1111, NB1222, NB2111, NB2222 and Cannabinoid platform NB3111. Its can …
  • Marquard & Bahls AG:企業の戦略的SWOT分析
    Marquard & Bahls AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Lysogene SAS (LYS):製薬・医療:M&Aディール及び事業提携情報
    Summary Lysogene SAS (Lysogene) is a clinical research center that offers basic research and clinical development programs. The center offers clinical development of gene therapy for neurodegenerative disorders such as Parkinson and Alzheimer diseases. It also develops models in gene therapy trials …
  • Mueller Water Products Inc (MWA):企業の財務・戦略的SWOT分析
    Summary Mueller Water Products Inc (Mueller Water) operates as an industrial equipment company. It manufactures and markets products for transmission, distribution and measurement of water. The company’s products include iron pipe, water metering products, fire hydrants, water and gas valves, and sy …
  • Heidelberg Pharma AG (WL6):企業の財務・戦略的SWOT分析
    Heidelberg Pharma AG (WL6) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Egyptian Resorts Co
    Egyptian Resorts Co - Strategy, SWOT and Corporate Finance Report Summary Egyptian Resorts Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Nitto Denko Corp (6988):製薬・医療:M&Aディール及び事業提携情報
    Summary Nitto Denko Corp (Nitto) is a manufacturer of diversified material, which produces electrical insulating material, electronics, industrial and functional products by harnessing its core technologies such as polymer synthesis, and adhesive and coating technologies. The company offers a broad …
  • Sunflower Electric Power Corp:企業の戦略的SWOT分析
    Sunflower Electric Power Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • University of Pennsylvania-医療機器分野:企業M&A・提携分析
    Summary University of Pennsylvania (UOP) is an educational university that provides distance learning facilities for professional courses. The university offers courses such as art and archaeology, accounting, biochemistry, bioengineering, biomedical graduate studies, city and regional planning, cri …
  • BioLineRx Ltd (BLRX):医療機器:M&Aディール及び事業提携情報
    Summary BioLineRx Ltd (BioLineRx) is a clinical stage biopharmaceutical company that focuses on the identification, in-licensing, and development of products to address unmet medical needs. The company focuses mainly on cancer and immunology. Its’s product pipeline includes BL-8040, a short peptide …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆